Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to 0.54.

  • Nuvation Bio's Equity Ratio fell 3840.63% to 0.54 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54, marking a year-over-year decrease of 3840.63%. This contributed to the annual value of 0.86 for FY2024, which is 1189.32% down from last year.
  • Latest data reveals that Nuvation Bio reported Equity Ratio of 0.54 as of Q3 2025, which was down 3840.63% from 0.58 recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Equity Ratio peaked at 0.98 during Q1 2023, and registered a low of 0.43 during Q2 2024.
  • Over the past 3 years, Nuvation Bio's median Equity Ratio value was 0.88 (recorded in 2024), while the average stood at 0.82.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 5559.8% in 2024, then soared by 3324.6% in 2025.
  • Over the past 3 years, Nuvation Bio's Equity Ratio (Quarter) stood at 0.97 in 2023, then fell by 11.89% to 0.86 in 2024, then plummeted by 36.85% to 0.54 in 2025.
  • Its Equity Ratio stands at 0.54 for Q3 2025, versus 0.58 for Q2 2025 and 0.85 for Q1 2025.